Your Search for alanine transaminase or alt or sgpt matched 1000 Documents (Page 1 of 34).
You may want to refine your search. Results Indexed by relevance.
Abstract: Our study shows that HIV pts rarely hide HBV occult infection. HIV pts present a previous HBV infection and a lack of immune function that could be facilitating factors for this infection. Probably an ARV therapy based on drugs which are active on HIV and HBV could inhibit HBV replication. Although much more research i ...
http://www.aegis.org/conferences/hiv-glasgow/2006/p311.html
File Name: p311.html, Size: 6KB, Last Modified: Sunday, November 12, 2006 at 8:12:04 PM
Abstract: ALT levels are not useful in the management of chronic hepatitis C in HIV infected patients: up to 17% of patients with no liver disease have abnormal levels, and up to 41% of patients with normal levels have severe liver damage. ...
http://www.aegis.org/conferences/hiv-glasgow/2006/p317.html
File Name: p317.html, Size: 6KB, Last Modified: Sunday, November 12, 2006 at 8:12:04 PM
Abstract: SAVE ADAP Alert ...
http://www.aegis.org/factshts/network/altcirrhosis.html
File Name: altcirrhosis.html, Size: 5KB, Last Modified: Friday, January 27, 2006 at 6:23:43 AM
Abstract: In the reported Asian lamivudine trial, the rate of hepatitis B e antigen (HBeAg) seroconversion, defined as HBeAg/hepatitis B virus (HBV) DNA seroclearance and development of anti-HBe, during 52 weeks of treatment was only 13% to 16%. To evaluate whether any factors influenced HBeAg seroconversion, data from 345 pati ...
http://www.aegis.org/aidsline/1999/nov/a99b0398.html
File Name: a99b0398.html, Size: 10KB, Last Modified: Sunday, November 28, 1999 at 8:12:04 PM
Abstract: BACKGROUND AND AIM: Serum alanine aminotransferase (ALT) level is the most common screening test as part of a routine evaluation of liver damage. In order to determine the factors influencing this liver function test in normal subjects, the relationship between ALT level and gender, age and body mass index (BMI) was s ...
http://www.aegis.org/aidsline/1999/aug/a9980475.html
File Name: a9980475.html, Size: 10KB, Last Modified: Saturday, August 28, 1999 at 8:12:04 PM
Abstract: This study was aimed to evaluate demographic, clinical, histological, and virological characteristics of 46 hepatitis C virus (HCV) carriers with persistently normal alanine transaminase (ALT) levels and to compare the results with those obtained in a group of 52 HCV-RNA-positive patients with elevated ALT levels. Sub ...
http://www.aegis.org/aidsline/1998/mar/m9830998.html
File Name: m9830998.html, Size: 9KB, Last Modified: Sunday, March 29, 1998 at 6:29:23 AM
Abstract: Long-term asymptomatic (ALT) status was defined as HIV infection for at least 8 years with stability of CD4 cell counts (greater than or equal to 600/mm(3)) and no antiretroviral therapy. As yet, fifty-eight patients have been enrolled in the study. At the time of the first virological evaluation following enrollment, ...
http://www.aegis.org/aidsline/1997/jul/m9770817.html
File Name: m9770817.html, Size: 9KB, Last Modified: Monday, July 28, 1997 at 8:12:04 PM
Abstract: Long-term asymptomatic (ALT) status was defined as HIV infection for at least 8 years with stability of CD4 cell counts (greater than or equal to 600/mm<sup><font size= ...
http://www.aegis.org/conferences/croi/1997/473.html
File Name: 473.html, Size: 6KB, Last Modified: Wednesday, January 22, 1997 at 8:12:04 PM
Abstract: BACKGROUND: In the context of a perinatal HIV Prevention trial in Thailand , severely immunocompromized women were offered HAART during pregnancy instead of enrolling in the study. METHODS: Immunocompromised Pregnant women who opted for HAART initiation received baseline clinical and biological evaluations and were fol ...
http://www.aegis.org/conferences/iac/2004/thpeb7088.html
File Name: thpeb7088.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM
Abstract: OBJECTIVES: Hepatitis C virus (HCV) is common in patients with end stage renal disease (ESRD) awaiting renal transplantation (RT). However, few data are available on the liver histology and viral titer in these patients relative to patients with HCV and normal renal function. The aims of this study were to assess live ...
http://www.aegis.org/aidsline/2000/mar/a0030589.html
File Name: a0030589.html, Size: 10KB, Last Modified: Tuesday, March 28, 2000 at 8:12:04 PM
Abstract: Around one fifth of the HIV-infected pts with HCV replication analyzed had normal transaminases. Females had more often normal transaminases compared to males. Therefore, HIV-infected pts with positive anti-HCV antibody need a complete evaluation including plasma HCV RNA levels even when transaminases are within normal ...
http://www.aegis.org/conferences/hiv-glasgow/2004/p235.html
File Name: p235.html, Size: 6KB, Last Modified: Sunday, November 14, 2004 at 8:12:04 PM
Abstract: BACKGROUND: To assess the risk of hepatotoxicity in patients co-infected with HIV and HBV and/or HCV initiating newer ARV agents. METHODS: A retrospective chart review was done on HIV patients co-infected with hepatitis from 2 Toronto centres. GEE logistic regression assessed the association between specific clinical a ...
http://www.aegis.org/conferences/iac/2004/mopeb3281.html
File Name: mopeb3281.html, Size: 6KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM
Abstract: It is justified to perform routine ALT measurements at baseline and 0.5M in specific risk-groups such as pregnant women, patients on hepatotoxic medication or those symptomatic for liver dysfunction. In all other patients, it would be acceptable to drop systematic ALT measurements at baseline and at M0.5. ...
http://www.aegis.org/conferences/iac/2006/wepe0087.html
File Name: wepe0087.html, Size: 9KB, Last Modified: Sunday, August 13, 2006 at 7:00:01 AM
Abstract: The reported hepatitis prevalence was relatively low. Bilirubin elevation was seen in the IDV/r arm. No clinically significant excess hepatotoxicity was seen in hepatitis patients compared to the overall study population during r-tx. ...
http://www.aegis.org/conferences/lipo/2003/126.html
File Name: 126.html, Size: 7KB, Last Modified: Wednesday, July 09, 2003 at 6:29:23 AM
Abstract: Incidence of transaminases elevation > 5N after PI–NNRTI switch was 10% (4/41) during the first year of follow-up. Intercurrent acute or chronic viral hepatitis was present in 3/4 patients. Moderate transaminases elevation was present at the time of PI–NNRTI switch in 22% of patients, 80% of whom having a co-infection ...
http://www.aegis.org/conferences/hiv-glasgow/2000/p161.html
File Name: p161.html, Size: 7KB, Last Modified: Sunday, October 22, 2000 at 8:12:04 PM
Abstract: Researchers measured serum alanine transaminase (ALT) levels, which are often used to select for treatment and liver biopsy in patients with hepatitis C virus, to test whether ALT levels vary over time in HCV-infected patients. They prospectively measured ALT levels for 25 months in 1,235 patients with a history of dru ...
http://www.aegis.org/news/ads/1999/ad990561.html
File Name: ad990561.html, Size: 10KB, Last Modified: Friday, April 09, 1999 at 3:00:00 PM
Abstract: <p><b>OBJECTIVE</b>: To assess the prevalence and the course of liver disease due to HBV, HDV and HCV chronic hepatitis (CH) in male homosexuals (OMO) with or without HIV infection.</p> <p><b>METHODS</b>: Research of HBV and HDV markers by RIA (Abbott), HCVab by ELISA (Abbott, second generation), HIVab by ELISA and ...
http://www.aegis.org/conferences/iac/1992/pob3466.html
File Name: pob3466.html, Size: 6KB, Last Modified: Sunday, July 19, 1992 at 8:12:04 PM
Abstract: In HIV infected patients (HIV+P) with chronic Hepatitis C (CHC), persistently normal alanine transaminase (PNALT) correlates with lower fibrosis scores than elevated ALT (EALT). The association found between HCV genotype, duration of HAART and PNALT in this population group merits further study. Although we did not fou ...
http://www.aegis.org/conferences/iashivpt/2005/tupe1-1c42.html
File Name: tupe1-1c42.html, Size: 9KB, Last Modified: Monday, July 25, 2005 at 6:29:23 AM
Abstract: BACKGROUND: To evaluate the effect of a combination of Nevirapine +Stavidine + Lamivudine on Heamatogical and Biochemical values of HIV-1 positive patients in Lagos. Methods and materials: Fifty patients who met the enrollment criteria for accelera ...
http://www.aegis.org/conferences/iac/2004/b10064.html
File Name: b10064.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM
Abstract: BACKGROUND: Hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV share the route of transmission. HBV or HCV co-infection with HIV has been associated with a reduced survival rate, increase the risk of progression to severe liver disease, and increase the risk of hepatotoxicity associated with active antiretrovira ...
http://www.aegis.org/conferences/iac/2004/tupec4682.html
File Name: tupec4682.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM
Abstract: We evaluated the safety and efficacy of long-term lamivudine monotherapy in a group of 25 patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. Lamivudine was administered in a daily dose of 150 mg for a mean of 26 +/- 7 months and ...
http://www.aegis.org/aidsline/2000/dec/a00c0202.html
File Name: a00c0202.html, Size: 10KB, Last Modified: Thursday, December 28, 2000 at 8:12:04 PM
Abstract: It has been suggested that hepatitis B e antigen (HBeAg) seroconversion after lamivudine therapy is durable in Caucasians with chronic hepatitis B (CHB). However, little is known whether it is also durable in endemic areas of hepatitis B virus (HBV) infection. We evaluated the posttreatment durability of lamivudine-in ...
http://www.aegis.org/aidsline/2000/dec/a00c0204.html
File Name: a00c0204.html, Size: 10KB, Last Modified: Thursday, December 28, 2000 at 8:12:04 PM
Abstract: Asian lamivudine trial has shown that hepatitis B e antigen (HBeAg) seroconversion rate during 1 year of lamivudine therapy was only 16% but was 64% in the subgroup of patients with a pretherapy serum alanine transaminase (ALT) level over 5 times the upper limit of normal (ULN). To test whether ALT rebound following c ...
http://www.aegis.org/aidsline/2000/nov/a00b0577.html
File Name: a00b0577.html, Size: 10KB, Last Modified: Tuesday, November 28, 2000 at 8:12:04 PM
Abstract: BACKGROUND & AIMS: One-year lamivudine therapy significantly suppressed hepatitis B virus (HBV) replication, improved hepatic necroinflammatory activity, and prevented progression of fibrosis. However, the effects of prolonged therapy are unknown. METHODS: A total of 334 Asian patients with chronic hepatitis B from ...
http://www.aegis.org/aidsline/2000/oct/a00a1014.html
File Name: a00a1014.html, Size: 9KB, Last Modified: Saturday, October 28, 2000 at 8:12:04 PM
Abstract: ...
http://www.aegis.org/aidsline/2000/jun/a0061162.html
File Name: a0061162.html, Size: 7KB, Last Modified: Wednesday, June 28, 2000 at 8:12:04 PM
Abstract: The prevalence and natural course of chronic hepatitis C virus (HCV) infection was evaluated in 15,250 consecutive pregnant women. The rate of HCV vertical and perinatal transmission was also assessed. The presence of anti-HCV was tested by means of EIA III and confirmed by recombinant immunoblot assay III. Alanine tr ...
http://www.aegis.org/aidsline/2000/may/a0051651.html
File Name: a0051651.html, Size: 10KB, Last Modified: Sunday, May 28, 2000 at 8:12:04 PM
Abstract: In patients with chronic hepatitis B, brief lamivudine therapy suppresses hepatitis B virus (HBV) DNA but results infrequently in sustained losses of virus replication posttreatment. We evaluated treatment response and its posttreatment durability during up to 18 months of lamivudine therapy (100 mg/d) in 24 patients ...
http://www.aegis.org/aidsline/1999/dec/a99c0216.html
File Name: a99c0216.html, Size: 9KB, Last Modified: Tuesday, December 28, 1999 at 8:12:04 PM
Abstract: Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication, but its long-term use may be associated with HBV tyrosine-methionine-aspartate-aspartate (YMDD) motif mutation. To examine the clinical features and course after emergence of YMD ...
http://www.aegis.org/aidsline/1999/oct/a99a0607.html
File Name: a99a0607.html, Size: 10KB, Last Modified: Thursday, October 28, 1999 at 8:12:04 PM
Abstract: The aim of this study was to assess the influence of human immunodeficiency virus (HIV) infection on chronic hepatitis B. In a series of 132 (65 anti-HIV positive) homosexual non-drug addicted men with chronic hepatitis B, the liver function was assessed with biochemical tests; the degree of hepatitis B virus (HBV) re ...
http://www.aegis.org/aidsline/1999/jul/a9970451.html
File Name: a9970451.html, Size: 9KB, Last Modified: Wednesday, July 28, 1999 at 8:12:04 PM
Abstract: Monitoring the progression of hepatitis C virus (HCV) includes clinical, biochemical, and histological parameters. Quantitation of viral load by reverse-transcription polymerase chain reaction (RT-PCR) may offer a more reliable marker of disease status. Conflicting reports on viral titers may reflect heterogeneity of ...
http://www.aegis.org/aidsline/1999/jun/a9960930.html
File Name: a9960930.html, Size: 10KB, Last Modified: Monday, June 28, 1999 at 8:12:04 PM